Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-12 · accession 0001061983-22-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-12 | 2022-05-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $37.54 | -14.0K | 168.1K | -8% | -$525.1K |
| D | 2022-05-12 | 2022-05-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +14.0K | 182.1K | +8% | +$135.0K |
| D | 2022-05-12 | 2022-05-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -14.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | S | D | 13,987 | $37.54 | 168,084 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-12 | M | A | 13,987 | $9.65 | 182,071 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (right to buy) | 2022-05-12 | M | D | 13,987 | $0.00 | 0 | D | $9.65 · 2014-03-24 to 2024-02-24 | 13,987 Common Stock |